Amit Sachdev

EVP Chief Patient & Ext Af Off, Vertex Pharmaceuticals

Bought, 12 months

$0.0M

Sold, 12 months

$28.4M

Companies

Latest trade

Feb 25, 2026

Companies

Vertex PharmaceuticalsEVP Chief Patient & Ext Af Off −$28.4M

Trades

VRTX Sold 1,846 shares at $486.35 · planned $0.9M Feb 25

VRTX Sold 58,613 shares at $468.83 · planned $27.5M Feb 19

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.